Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Etamsylate

Etamsylate

pharmaceutical raw materials
Etamsylate structure

Etamsylate 

structure
  • CAS No:

    2624-44-4

  • Formula:

    C6H6O5S.C4H11N

  • Chemical Name:

    Etamsylate

  • Synonyms:

    Benzenesulfonic acid,2,5-dihydroxy-,compd. with N-ethylethanamine (1:1);Benzenesulfonic acid,2,5-dihydroxy-,compd. with diethylamine (1:1);Benzenesulfonic acid,2,5-dihydroxy-,compd. with Et2NH;Diethylamine,2,5-dihydroxybenzenesulfonate;Ethanamine,N-ethyl-,2,5-dihydroxybenzenesulfonate;141 MD;Dicynene;Dicynone;Diethylammonium 2,5-dihydroxybenzenesulfonate;Ethamsylate;Cyclonamine;Eselin;Aglumin;Altodor;Etamsylate;2,5-Dihydroxybenzenesulfonic acid diethylamine salt;Dicinone;Biosinon;MD 141;E 141;K-Stat;Hemsyl;Sylate

  • Categories:

    Active Pharmaceutical Ingredients  >  Blood System Drugs

Description

Ethamsylate is a haemostatic drug, also inhibits biosynthesis and action of those prostaglandins.


Etamsylate is a sulfonic acid derivative and an organosulfur compound.|Benzenesulfonate derivative used as a systemic hemostatic.

Etamsylate Basic Attributes

263.31

263.082733

220-090-7

24YL531VOH

DTXSID4045559

B02BX01|B - Blood and blood forming organs

2922299090

Characteristics

115

2.43200

White crystals or crystalline powder

1.3441 (rough estimate)

125 °C

496.4°C at 760 mmHg

254ºC

1.13E-10mmHg at 25°C

LD50 i.v. in mice, rats: 800, 1350 mg/kg (Esteve)

Safety Information

IRRITANT

DB6145000

P201, P202, P281, P308+P313, P405, P501

H361

|Warning|H319 (97.22%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]|P264, P280, P305+P351+P338, and P337+P313|Aggregated GHS information provided by 41 companies from 3 notifications to the ECHA C&L Inventory.

Drug Information

Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)

Altodor

Etamsylate Use and Manufacturing

Uses

Hemostatic;prostaglandin synthesis inhibitor he product can increase the number, aggregation and adhesion of platelets, and promote the release of coagulation active substances from platelets. It can also accelerate the contraction of blood clots, shorten the clotting time, enhance the resistance of capillaries, and reduce capillary permeability. Used to prevent and treat bleeding before surgery. It is also used for bleeding caused by platelet insufficiency or other causes, such as gastrointestinal bleeding, cerebral hemorrhage and urinary tract bleeding.

Benzenesulfonic acid, 2,5-dihydroxy-, compd. with N-ethylethanamine (1:1): INACTIVE

Human drugs -> Rare disease (orphan)

Computed Properties

Molecular Weight:263.31
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:3
Exact Mass:263.08274382
Monoisotopic Mass:263.08274382
Topological Polar Surface Area:115
Heavy Atom Count:17
Complexity:252
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Material

Drug Function and Efficacy

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Double-Crane Pharmaceutical(Shangqiu) Co., Ltd.

    China China
    Active
  • China Resources Double-Crane Pharmaceutical Co., Ltd.

    China China
    Active
  • Hunan Er-Kang Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Etamsylate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.